Article Information
PubMed
Print ISSN
Online ISSN
History
- Received July 11, 2010
- Accepted November 2, 2010
- Published online January 18, 2011.
Article Versions
- Earlier version (November 2, 2010 - 12:12).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Cecilia Renzulli,
- Mike Nash,
- Mark Wright,
- Steven Thomas,
- Stefano Zamuner,
- Mario Pellegatti,
- Paolo Bettica and
- Gary Boyle
- Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Verona, Italy (C.R., M.P.); Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline Research and Development, Ware, United Kingdom (M.N., M.W., S.T., G.B.); Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline Research and Development, Verona, Italy (S.Z.); and Discovery Medicine, GlaxoSmithKline Research and Development, Verona, Italy (P.B.)
- Address correspondence to:
Gary Boyle, DMPK, GlaxoSmithKline, Ware, UK. E-mail: gary.w.boyle{at}gsk.com
Statistics from Altmetric.com
Article usage
In this issue
Disposition and Metabolism of [14C]SB-649868, an Orexin 1 and 2 Receptor Antagonist, in Humans
